Publications dans lesquelles il/elle collabore avec Gustavo Puras Ochoa (32)

2024

  1. Carbon-Based Nanostructures as Emerging Materials for Gene Delivery Applications

    Pharmaceutics, Vol. 16, Núm. 2

2023

  1. 3D Bioprinting for Musculoskeletal Applications

    3D Printing and Bioprinting for Pharmaceutical and Medical Applications (CRC Press), pp. 147-168

  2. 3D Bioprinting for Ocular Applications

    3D Printing and Bioprinting for Pharmaceutical and Medical Applications (CRC Press), pp. 221-245

  3. Bektore ez-biral lipidikoak garatzeko erabiltzen diren teknikak eta hauen garrantzia etorkizunerako

    Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.

2021

  1. Applying 3D constructs for gene therapy

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 93-95

  2. Design and validation of a process based on cationic niosomes for gene delivery into novel urine-derived mesenchymal stem cells

    Pharmaceutics, Vol. 13, Núm. 5

  3. How far are non‐viral vectors to come of age and reach clinical translation in gene therapy?

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2019

  1. Cationic niosomes as non-viral vehicles for nucleic acids: Challenges and opportunities in gene delivery

    Pharmaceutics, Vol. 11, Núm. 2

  2. Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 308-318

2018

  1. Hyaluronic acid hydrogel scaffolds loaded with cationic niosomes for efficient non-viral gene delivery

    RSC Advances, Vol. 8, Núm. 56, pp. 31934-31942

  2. Polysorbate 20 non-ionic surfactant enhances retinal gene delivery efficiency of cationic niosomes after intravitreal and subretinal administration

    International Journal of Pharmaceutics, Vol. 550, Núm. 1-2, pp. 388-397

  3. Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 14, Núm. 2, pp. 521-531

2017

  1. Amine containing cationic methacrylate copolymers as efficient gene delivery vehicles to retinal epithelial cells

    Journal of Polymer Science, Part A: Polymer Chemistry, Vol. 55, Núm. 2, pp. 280-287

  2. Cationic nioplexes-in-polysaccharide-based hydrogels as versatile biodegradable hybrid materials to deliver nucleic acids

    Journal of Materials Chemistry B, Vol. 5, Núm. 37, pp. 7756-7767

  3. Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis

    Drug Development and Industrial Pharmacy, Vol. 43, Núm. 7, pp. 1071-1081

  4. Non-viral vectors based on magnetoplexes, lipoplexes and polyplexes for VEGF gene delivery into central nervous system cells

    International Journal of Pharmaceutics, Vol. 521, Núm. 1-2, pp. 130-140

2016

  1. Elaboration and physicochemical characterization of niosome-based nioplexes for gene delivery purposes

    Methods in Molecular Biology (Humana Press Inc.), pp. 63-75

  2. Nioplexes encapsulated in supramolecular hybrid biohydrogels as versatile delivery platforms for nucleic acids

    RSC Advances, Vol. 6, Núm. 46, pp. 39688-39699

  3. The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain

    Biomaterials, Vol. 77, pp. 267-279

  4. The role of helper lipids in the intracellular disposition and transfection efficiency of niosome formulations for gene delivery to retinal pigment epithelial cells

    International Journal of Pharmaceutics, Vol. 503, Núm. 1-2, pp. 115-126